| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,114 | 0,119 | 10.12. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | SpineGuard announces the launch of a capital increase with cancellation of preferential subscription rights and implementation of a priority period for shareholders for an initial gross amount of €1.6 million secured by commitments amounting to... | 218 | Business Wire | Subscription price: €0.1120 per share, representing a discount of 25.93% on the closing price of the share on December 8th, 2025 Priority period open from December 9th, 2025, to December... ► Artikel lesen | |
| 04.12. | SpineGuard Obtains the Clearance of Three New PediGuard Models in China | 219 | Business Wire | Extension to add the Curved and XS PediGuard models
Designation change
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 24.11. | SpineGuard Obtains a U.S. Patent on Its Universal Adapter for Orthopaedic Power Drills and Robots | 216 | Business Wire | Bone breach detection, automatic stop and additional functionalities
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 09.10. | SpineGuard Reports Its Q3 2025 Revenue | 326 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 22.09. | SpineGuard Obtains European Patent on Automatic Bone Breach Detection by DSG, Applicable to Orthopedic Power Drills and Robots | 307 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline... ► Artikel lesen | |
| 10.09. | SpineGuard Reports 2025 Half-Year Results and Announces the Implementation of a Bond Financing | 498 | Business Wire | 54% improvement in operating result Implementation of a bond financing for up to €1,000,000
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its... ► Artikel lesen | |
| 16.07. | SpineGuard Obtains US Patent on DSG-Enabled Active Safety Stop for Hand-Held Bone Drilling Power Tools in Free-Hand, Navigated or Robotically-Assisted Surgery | 440 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| SPINEGUARD Aktie jetzt für 0€ handeln | |||||
| 09.07. | SpineGuard Announces Its H1 2025 Revenue | 390 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 29.04. | Presentation at CFA Congress of Positive Results Obtained for SpineGuard's New Ultrasound Technology | 477 | Business Wire | Feasibility of entry point and trajectory determination in vertebral drilling
Ideal complement of DSG real-time X Ray-free guidance technology
Collaboration with the LIB and ISIR... ► Artikel lesen | |
| 15.04. | SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales | 468 | Business Wire | Significant reduction in losses of €1.1 million, with consolidated net income improving by 26% in 2024
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen | |
| 09.04. | SpineGuard and Omnia Medical Announce the Signature of a Binding Term Sheet for the Transfer of SpineGuard Inc. | 389 | Business Wire | Taking a new strategic step forward in the implementation of the common roadmap established by the two companies announced on January 6, 2025 Integration of PediGuard systems into Omnia... ► Artikel lesen | |
| 14.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | 1.856 | Xetra Newsboard | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
| 10.02. | SpineGuard Announces the Commercial Launch of its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 482 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Omnia launched PsiFGuard at the NANS convention in Orlando, from Jan. 30th to Feb. 1st, 2025
Regulatory News:
SpineGuard... ► Artikel lesen | |
| 10.01. | SpineGuard Reports Its Full-Year 2024 Revenue | 724 | Business Wire | +8% growth globally, +20% in the US
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology... ► Artikel lesen | |
| 07.01. | SpineGuard Completes a Bond Financing to Support the Deployment of Its New Products | 1.071 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 06.01. | SpineGuard and Omnia Medical Announce the Extension of Their Strategic Partnership | 584 | Business Wire | Scope of initial agreement extended to other products and countries Reallocation of personnel and resources to bolster the launch of Omnia products in the United States including PsiFGuard
Regulatory... ► Artikel lesen | |
| 03.01. | SpineGuard announces its 2025 financial calendar | 592 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,030 | +2,85 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach den Anfang November vorgelegten Zahlen zum dritten Quartal von 56 auf 57 Euro angehoben. Die Einstufung wurde... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,210 | -1,23 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers nach dem jährlichen Treffen der US-Radiologen mit einem Kursziel von 61,30 Euro auf "Overweight" belassen.... ► Artikel lesen | |
| TELADOC HEALTH | 6,500 | -1,92 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Financial Officer Transition | NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial... ► Artikel lesen | |
| THERMO FISHER | 488,45 | +0,86 % | If You Invested $100 In Thermo Fisher Scientific Stock 10 Years Ago, You Would Have This Much Today | ||
| EUROFINS SCIENTIFIC | 57,64 | +1,77 % | The Eurofins Consumer Product Testing Network Completes Significant Laboratory Expansion in Vietnam | Eurofins Consumer Product Testing Vietnam has completed a major expansion, seeing the laboratory move to a purpose-built 7,000 sq. m laboratory in Ho Chi Minh City. This new facility provides more... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| DAVITA | 100,05 | -0,35 % | Catalyzing Change in Specialty Care: DaVita Shares Vision for Technology Transformation | NORTHAMPTON, MA / ACCESS Newswire / December 2, 2025 / Approximately 129 million Americans are living with at least one chronic condition, and fragmentation of care creates a significant hurdle as these... ► Artikel lesen | |
| SPINEWAY | 0,145 | -3,07 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| DENTSPLY SIRONA | 9,932 | +4,00 % | Dentsply Sirona Inc Q3 Earnings Summary | WASHINGTON (dpa-AFX) - Below are the earnings highlights for Dentsply Sirona Inc (XRAY):Earnings: -$427 million in Q3 vs. -$494 million in the same period last year.
EPS: -$2.14 in Q3 vs.... ► Artikel lesen | |
| SMITH & NEPHEW | 14,450 | +0,84 % | Ihre wichtigsten Termine: Alle Augen auf: Stabilus, Smith & Nephew sowie Konjunkturdaten aus China & Japan | Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00 Uhr, Luxemburg: Stabilus... ► Artikel lesen | |
| SONIC HEALTHCARE | 13,000 | -1,57 % | Laufende Fusionskontrollverfahren: Sonic Healthcare Limited, Sydney /Australien; Erwerb eines Mehrheitsanteils an und alleiniger Kontrolle über die Medizinisches Versorgungszentrum Labor Dr. Klein Dr. Schmitt GmbH, Kaiserslautern | Datum der Anmeldung:31.10.2025Aktenzeichen:B3-103/25Unternehmen:Sonic Healthcare Limited, Sydney/Australien; Erwerb eines Mehrheitsanteils an und alleiniger Kontrolle über die Medizinisches Versorgungszentrum... ► Artikel lesen | |
| ONTRAK | 0,319 | -14,99 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 26.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.08.2025.ISIN NameAU0000006934 NEW... ► Artikel lesen | |
| DIASORIN | 61,54 | +1,02 % | Milan: DiaSorin on the rise | ||
| FULGENT GENETICS | 23,400 | -0,85 % | Raymond James erhöht Kursziel für Fulgent Genetics nach starken Zahlen auf 36 US-Dollar | ||
| IMPLANTICA | 4,765 | -0,83 % | Implantica strengthens market expansion as Italy's leading Careggi University Hospital in Florence introduces RefluxStop | VADUZ, Liechtenstein, Dec. 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device... ► Artikel lesen |